Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Hey Bob, we need more smoke and mirrors.

<< Previous

Bullboard Posts

Next >>

Post by losingmyshirton Dec 23, 2021 11:08am

301 Views

Post# 34257977

Hey Bob, we need more smoke and mirrors.

Yesterday's big increase came as a surprise to all. Too bad the attempt to jumpstart this POS did not succeed. Obviously it was a risky move but in the end it didn't cost them that much.

Too bad. Bob failed again. DUMP BOB.......Wait..We can't dump Bob. He is the only employee. If we dump him, who will give him his termination notice?

Bugger that, dump him anyways for looking like thta old guy from the movie UP.

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”